Literature DB >> 15258090

Emergent human pathogen simian virus 40 and its role in cancer.

Regis A Vilchez1, Janet S Butel.   

Abstract

The polyomavirus simian virus 40 (SV40) is a known oncogenic DNA virus which induces primary brain and bone cancers, malignant mesothelioma, and lymphomas in laboratory animals. Persuasive evidence now indicates that SV40 is causing infections in humans today and represents an emerging pathogen. A meta-analysis of molecular, pathological, and clinical data from 1,793 cancer patients indicates that there is a significant excess risk of SV40 associated with human primary brain cancers, primary bone cancers, malignant mesothelioma, and non-Hodgkin's lymphoma. Experimental data strongly suggest that SV40 may be functionally important in the development of some of those human malignancies. Therefore, the major types of tumors induced by SV40 in laboratory animals are the same as those human malignancies found to contain SV40 markers. The Institute of Medicine recently concluded that "the biological evidence is of moderate strength that SV40 exposure could lead to cancer in humans under natural conditions." This review analyzes the accumulating data that indicate that SV40 is a pathogen which has a possible etiologic role in human malignancies. Future research directions are considered.

Entities:  

Keywords:  Non-programmatic

Mesh:

Year:  2004        PMID: 15258090      PMCID: PMC452549          DOI: 10.1128/CMR.17.3.495-508.2004

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  126 in total

Review 1.  New associations of human papillomavirus, Simian virus 40, and Epstein-Barr virus with human cancer.

Authors:  May Wong; Joseph S Pagano; John T Schiller; Satvir S Tevethia; Nancy Raab-Traub; Jack Gruber
Journal:  J Natl Cancer Inst       Date:  2002-12-18       Impact factor: 13.506

Review 2.  Effect of fixatives and tissue processing on the content and integrity of nucleic acids.

Authors:  Mythily Srinivasan; Daniel Sedmak; Scott Jewell
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

3.  Pathogenesis and management of polyomavirus infection in transplant recipients.

Authors:  Eun Jeong Kwak; Regis A Vilchez; Parmjeet Randhawa; Ron Shapiro; Janet S Butel; Shimon Kusne
Journal:  Clin Infect Dis       Date:  2002-11-01       Impact factor: 9.079

Review 4.  SV40 and human tumours: myth, association or causality?

Authors:  Adi F Gazdar; Janet S Butel; Michele Carbone
Journal:  Nat Rev Cancer       Date:  2002-12       Impact factor: 60.716

Review 5.  Papillomaviruses and cancer: from basic studies to clinical application.

Authors:  Harald zur Hausen
Journal:  Nat Rev Cancer       Date:  2002-05       Impact factor: 60.716

Review 6.  T antigens of simian virus 40: molecular chaperones for viral replication and tumorigenesis.

Authors:  Christopher S Sullivan; James M Pipas
Journal:  Microbiol Mol Biol Rev       Date:  2002-06       Impact factor: 11.056

7.  Reappraisal of the strong association between simian virus 40 and human malignant mesothelioma of the pleura (Belgium).

Authors:  Roland Hübner; Eric Van Marck
Journal:  Cancer Causes Control       Date:  2002-03       Impact factor: 2.506

8.  Absence of simian virus 40 in human brain tumors from northern India.

Authors:  Eric A Engels; Chitra Sarkar; Richard W Daniel; Patti E Gravitt; Kusum Verma; Martha Quezado; Keerti V Shah
Journal:  Int J Cancer       Date:  2002-10-01       Impact factor: 7.396

9.  A controlled trial of a human papillomavirus type 16 vaccine.

Authors:  Laura A Koutsky; Kevin A Ault; Cosette M Wheeler; Darron R Brown; Eliav Barr; Frances B Alvarez; Lisa M Chiacchierini; Kathrin U Jansen
Journal:  N Engl J Med       Date:  2002-11-21       Impact factor: 91.245

10.  Molecular identification of SV40 infection in human subjects and possible association with kidney disease.

Authors:  Rui-Mei Li; Mary H Branton; Somsak Tanawattanacharoen; Ronald A Falk; J Charles Jennette; Jeffrey B Kopp
Journal:  J Am Soc Nephrol       Date:  2002-09       Impact factor: 10.121

View more
  35 in total

1.  Variable frequency of polyomavirus SV40 and herpesvirus EBV in lymphomas from two different urban population groups in Houston, TX.

Authors:  Sonia Toracchio; Claudia A Kozinetz; Deanna E Killen; Andrea M Sheehan; Eugenio I Banez; Michael M Ittmann; Vojtech Sroller; Janet S Butel
Journal:  J Clin Virol       Date:  2009-07-23       Impact factor: 3.168

2.  Targeting mesothelioma using an infectivity enhanced survivin-conditionally replicative adenoviruses.

Authors:  Zeng B Zhu; Sharmila K Makhija; Baogen Lu; Minghui Wang; Shuyi Wang; Koichi Takayama; Gene P Siegal; Paul N Reynolds; David T Curiel
Journal:  J Thorac Oncol       Date:  2006-09       Impact factor: 15.609

Review 3.  Clinical diagnosis of malignant pleural mesothelioma.

Authors:  Andrea Bianco; Tullio Valente; Maria Luisa De Rimini; Giacomo Sica; Alfonso Fiorelli
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

Review 4.  Enteric Virome and Carcinogenesis in the Gut.

Authors:  Cade Emlet; Mack Ruffin; Regina Lamendella
Journal:  Dig Dis Sci       Date:  2020-03       Impact factor: 3.199

Review 5.  The role of polyomaviruses in human disease.

Authors:  Mengxi Jiang; Johanna R Abend; Silas F Johnson; Michael J Imperiale
Journal:  Virology       Date:  2008-11-07       Impact factor: 3.616

6.  Viral regulatory region effects on vertical transmission of polyomavirus SV40 in hamsters.

Authors:  Niraj C Patel; Steven J Halvorson; Vojtech Sroller; Amy S Arrington; Connie Wong; E O'Brian Smith; Regis A Vilchez; Janet S Butel
Journal:  Virology       Date:  2009-01-31       Impact factor: 3.616

7.  New treatment options in the management of glioblastoma multiforme: a focus on bevacizumab.

Authors:  Argirios Moustakas; Teri N Kreisl
Journal:  Onco Targets Ther       Date:  2010-06-24       Impact factor: 4.147

8.  Detection of polyomavirus SV40 in tonsils from immunocompetent children.

Authors:  Niraj C Patel; Regis A Vilchez; Deanna E Killen; Preeti Zanwar; Vojtech Sroller; Karen W Eldin; Dolores López-Terrada; Janet S Butel
Journal:  J Clin Virol       Date:  2008-06-09       Impact factor: 3.168

9.  An SV40 VP1-derived epitope recognized by CD8+ T cells is naturally processed and presented by HLA-A*0201 and cross-reactive with human polyomavirus determinants.

Authors:  Hephzibah Rani S Tagaram; Alan M Watson; Francois A Lemonnier; Kevin Staveley-O'Carroll; Satvir S Tevethia; Todd D Schell
Journal:  Virology       Date:  2008-04-10       Impact factor: 3.616

Review 10.  Regulation of gene expression in primate polyomaviruses.

Authors:  Martyn K White; Mahmut Safak; Kamel Khalili
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.